PUMA BIOTECHNOLOGY, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Puma Biotechnology, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • Puma Biotechnology, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 345 %, a 51.9% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 345 -372 -51.9% Jun 30, 2024
Q1 2024 389 -418 -51.8% Mar 31, 2024
Q4 2023 460 -594 -56.4% Dec 31, 2023
Q3 2023 605 -1.05K -63.5% Sep 30, 2023
Q2 2023 718 -5.45K -88.4% Jun 30, 2023
Q1 2023 807 -3.02K -78.9% Mar 31, 2023
Q4 2022 1.05K -1.84K -63.6% Dec 31, 2022
Q3 2022 1.66K -1.66K -50% Sep 30, 2022
Q2 2022 6.17K +3.67K +147% Jun 30, 2022
Q1 2022 3.83K +845 +28.3% Mar 31, 2022
Q4 2021 2.89K -779 -21.2% Dec 31, 2021
Q3 2021 3.32K +1.44K +76.5% Sep 30, 2021
Q2 2021 2.5K +1.18K +89.6% Jun 30, 2021
Q1 2021 2.98K +1.67K +127% Mar 31, 2021
Q4 2020 3.67K +2.73K +291% Dec 31, 2020
Q3 2020 1.88K +1.07K +132% Sep 30, 2020
Q2 2020 1.32K +689 +109% Jun 30, 2020
Q1 2020 1.32K +770 +141% Mar 31, 2020
Q4 2019 939 +535 +132% Dec 31, 2019
Q3 2019 810 +503 +164% Sep 30, 2019
Q2 2019 629 +403 +178% Jun 30, 2019
Q1 2019 547 +425 +347% Mar 31, 2019
Q4 2018 404 +329 +436% Dec 31, 2018
Q3 2018 307 +264 +615% Sep 30, 2018
Q2 2018 226 +194 +609% Jun 30, 2018
Q1 2018 123 +92.5 +308% Mar 31, 2018
Q4 2017 75.5 +46.8 +163% Dec 31, 2017
Q3 2017 43 +15.7 +57.4% Sep 30, 2017
Q2 2017 31.9 +12.4 +63.9% Jun 30, 2017
Q1 2017 30 +15.6 +108% Mar 31, 2017
Q4 2016 28.7 +17.4 +155% Dec 31, 2016
Q3 2016 27.3 +13.7 +101% Sep 30, 2016
Q2 2016 19.5 +3.8 +24.2% Jun 30, 2016
Q1 2016 14.4 -3.76 -20.7% Mar 31, 2016
Q4 2015 11.2 -9.05 -44.6% Dec 31, 2015
Q3 2015 13.6 -3.57 -20.8% Sep 30, 2015
Q2 2015 15.7 -1.08 -6.45% Jun 30, 2015
Q1 2015 18.2 +1.02 +5.94% Mar 31, 2015
Q4 2014 20.3 -0.61 -2.92% Dec 31, 2014
Q3 2014 17.1 -2.21 -11.4% Sep 30, 2014
Q2 2014 16.8 -9.12 -35.2% Jun 30, 2014
Q1 2014 17.2 -14.3 -45.5% Mar 31, 2014
Q4 2013 20.9 -16 -43.3% Dec 31, 2013
Q3 2013 19.3 -21.8 -53% Sep 30, 2013
Q2 2013 25.9 +3.41 +15.2% Jun 30, 2013
Q1 2013 31.5 +19.4 +162% Mar 31, 2013
Q4 2012 36.9 Dec 31, 2012
Q3 2012 41.2 Sep 30, 2012
Q2 2012 22.5 Jun 30, 2012
Q1 2012 12 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.